Treatment Outcomes for Ankle Arthritis

NCT00391365 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 368

Last updated 2026-01-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine any functional outcome differences in patients who have undergone surgical treatment for ankle osteoarthritis using surveys, step counts, and laboratory gait analysis.

This study is closed to recruitment; follow-up procedures are completed; the study remains open for data analysis. Enrollment was completed by August 2012.

As of July 2016, the study is currently analyzing data.

In April 2017 the study was approved to begin long term follow-up with study participants. Study personnel contact participants via telephone and/or U.S. Mail to tell them about long term follow-up, and to ask whether they are willing to continue study participation. Long term follow-up will be for up to 12 years after the participant's ankle surgery.

Conditions

Interventions

PROCEDURE

Gait analysis

Subjects will come into motion analysis laboratory at the VA Puget Sound Health Care System. A standard set of body measurements will be taken using calipers, a measuring tape, and a scale (for example height, weight, leg length, foot length, etc). The investigators will then attach small reflective markers to the body using double-sided tape and ask the participants to walk several times as the motion of each marker is recorded by infrared cameras.

Sponsors & Collaborators

  • Orthopaedic Associates of Michigan (Grand Rapids, MI)

    collaborator UNKNOWN
  • Orthopedic + Fracture Specialists, Portland, OR

    collaborator OTHER
  • Minnesota Orthopedic Sports Medicine Institute Twin Cities Orthopedics (Edina, MN)

    collaborator UNKNOWN
  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Bruce J. Sangeorzan, MD · VA Puget Sound Health Care System Seattle Division, Seattle, WA

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-01
Primary Completion
2015-08-01
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00391365 on ClinicalTrials.gov